Prediabetes en Perú: consenso de expertos

Abstract

Objective: To collect information of prediabetes in the Peruvian context. Methods: 9 national experts were summoned and a scoring questionnaire was prepared for screening dimensions as diagnosis, tools to determine the risk of progression to DM2, risk factors and management of prediabetes for the prevention of DM2. The consensus was made in three rounds, being the third one, face-to-face. Findings: Fasting plasma glucose is the best test for prediabetes screening. The best cut-off point is the one recommended by the American Diabetes Association (100 mg/dl to 125 mg/dl or 5.6-6.9 mmol/L). Every patient with altered fasting plasma glucose should undergo an oral glucose tolerance test with 75 g of anhydrous glucose. PERUDIAB study is the best population analysis that estimated an impaired fasting glucose prevalence of 22.4%. The options are: lifestyle change or this one but with metformin. Conclusion: This document is essential to establish pre-diabetes prevention policies, identifying risk populations and screening tools.

Cardiovascular risk, fatty liver disease, glucose and insulin curve among prediabetes phenotypes in Peruvian population

“… 5 However, a Peruvian expert consensus suggested this could be an approximate estimation of prediabetes prevalence in the country underestimated by not using OGTT. 6 …”